RE: Great news Uk Gov investment28 Aug 2024 21:18
Up to £400 million of investment will support faster patient access to cutting-edge treatments, strengthen clinical trials and improve medicines manufacturing in the UK18 new clinical trials hubs will be created across UK to accelerate research
NHS patients will have earlier access to new treatments and the UK will become the home of cutting-edge health research as the UK government launches a joint public-private investment programme worth up to £400 million.
The Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) Investment Programme opens today. It will channel significant investment into the UK’s health and life sciences sector over the next 5 years, boosting economic growth and the global competitiveness of the UK’s life sciences sector.
It is the first major public-private collaboration of this scale in the world and will strengthen the NHS through supporting innovative research, creating 18 new clinical trial hubs to fast-track the development of new medicines to patients. By streamlining processes, it will ensure that new treatments move swiftly from labs to wards, providing patients with faster access to cutting-edge treatments.